AbbVie is boosting its already strong presence in immunology with the acquisition of Apogee Therapeutics, a clinical-stage biotech whose most advanced drug candidate could bring advantages over several currently available

Abarca Health and LucyRx announced last week that they are combining to build an independent pharmacy benefit manager serving commercial and government clients. Together, they’ll support more than 9 million

For decades, employer-sponsored healthcare relied on the same predictable levers to manage spending. Employers rolled out higher deductibles, narrower networks, and increased cost sharing. But a more meaningful shift is

The case that many startups are making for automating the healthcare revenue cycle is pretty straightforward. Claims follow rules, payers adhere to guidelines, and most of this work is repetitive

For both the builders and users of clinical AI, bias remains one of the single greatest issues keeping the industry up at night. The prevailing anxiety revolves around one urgent

In January 2026, CMS launched the Wasteful and Inappropriate Service Reduction (WISeR) model, introducing prior authorization into traditional Medicare for certain services in selected states. However, this controversial program could

Over the last decade, organ preservation has gone from hardware store coolers filled with ice to high-tech preservation systems that have been shown to significantly increase organ viability and patient

In February, Waymo’s chief safety officer testified before the U.S. Senate that remote operators in the Philippines help guide its supposedly autonomous vehicles. The headline was about outsourcing. The real

The FDA now agrees uniQure’s clinical data for its Huntington’s disease gene therapy can support a regulatory submission in this rare neurodegenerative disorder, reversing its stance just a few months

The healthcare industry has made its decision: AI is the answer to physician burnout. Ambient scribes, automated documentation, clinical co-pilots, the investment is real and the early data on reducing